Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry.

Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Coenen JLLM, van den Bergh ACMF, Mehra N, Somford DM, Bergman AM, Ten Bokkel Huinink D, Fossion L, Geenen MM, Hendriks MP, van de Luijtgaarden ACM, Polee MB, Weijl NI, van de Wouw AJ, de Wit R, Uyl-de Groot CA, Gerritsen WR.

Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30146-4. doi: 10.1016/j.euo.2019.09.005. [Epub ahead of print]

PMID:
31601523
2.

Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategy.

van Tol-Geerdink JJ, van Oort IM, Somford DM, Wijburg CJ, Geboers A, van Uden-Kraan CF, de Vries M, Stalmeier PF.

Health Informatics J. 2019 Sep 30:1460458219873528. doi: 10.1177/1460458219873528. [Epub ahead of print]

PMID:
31566466
3.

Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.

Wegelin O, Exterkate L, van der Leest M, Kelder JC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE.

Eur Urol Oncol. 2019 Sep 10. pii: S2588-9311(19)30133-6. doi: 10.1016/j.euo.2019.08.007. [Epub ahead of print]

PMID:
31519516
4.

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative.

Cuypers M, Al-Itejawi HHM, van Uden-Kraan CF, Stalmeier PFM, Lamers RED, van Oort IM, Somford DM, van Moorselaar RJA, Verdonck-de Leeuw IM, van de Poll-Franse LV, van Tol-Geerdink JJ, de Vries M.

J Cancer Educ. 2019 Jul 5. doi: 10.1007/s13187-019-01572-9. [Epub ahead of print]

PMID:
31278659
5.

Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?

Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, van Melick HHE, Somford DM.

Eur Urol Oncol. 2019 Jun 22. pii: S2588-9311(19)30080-X. doi: 10.1016/j.euo.2019.06.005. [Epub ahead of print]

PMID:
31239236
6.

External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients.

Hueting TA, Cornel EB, Somford DM, Jansen H, van Basten JA, Pleijhuis RG, Korthorst RA, van der Palen JAM, Koffijberg H.

Eur Urol Oncol. 2018 Oct;1(5):411-417. doi: 10.1016/j.euo.2018.04.016. Epub 2018 Jun 28.

PMID:
31158080
7.

[Complications after intravesical BCG instillation].

Privé BM, Bruins HM, Mulder B, Somford DM.

Ned Tijdschr Geneeskd. 2019 May 3;163. pii: D3277. Dutch.

PMID:
31120204
8.

The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.

Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE.

Eur Urol. 2019 Apr;75(4):582-590. doi: 10.1016/j.eururo.2018.11.040. Epub 2018 Dec 3.

PMID:
30522912
9.

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors.

Jansen H, van Oort IM, van Andel G, Wijsman BP, Pos FJ, Hulshof MCCM, Hulsbergen-van de Kaa CA, van Leenders GJLH, Fütterer JJ, Somford DM, Busstra MB, van Moorselaar RJA, Kiemeney LA, Aben KKH.

Prostate Cancer Prostatic Dis. 2019 May;22(2):337-343. doi: 10.1038/s41391-018-0109-y. Epub 2018 Nov 14.

PMID:
30429595
10.

[Incidence of incontinence after radical prostatectomy using claims-based data].

Schepens MHJ, Ziedses des Plantes CMP, Somford DM, van Erkelens JA, Cremers RG, de Vries S, Aben KKH, Hoekstra R, Stienen JJC, Wijsman BP, Busstra MB, van Limbeek J.

Ned Tijdschr Geneeskd. 2018;162:D2294. Dutch.

PMID:
29676710
11.

Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate Cancer.

Benoist GE, van der Meulen E, van Oort IM, Beumer JH, Somford DM, Schalken JA, Burger DM, van Erp NP.

Ther Drug Monit. 2018 Apr;40(2):222-229. doi: 10.1097/FTD.0000000000000484.

12.

Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.

Hamoen EHJ, Hoeks CMA, Somford DM, van Oort IM, Vergunst H, Oddens JR, Smits GA, Bokhorst LP, Witjes JA, Rovers MM, Hulsbergen-van de Kaa CA, Barentsz JO.

Eur Urol Focus. 2019 May;5(3):407-415. doi: 10.1016/j.euf.2017.12.008. Epub 2018 Jan 10.

PMID:
29331622
13.

Incidence and Risk Factors of Postoperative Urinary Retention and Bladder Catheterization in Patients Undergoing Fast-Track Total Joint Arthroplasty: A Prospective Observational Study on 371 Patients.

Scholten R, Kremers K, van de Groes SAW, Somford DM, Koëter S.

J Arthroplasty. 2018 May;33(5):1546-1551. doi: 10.1016/j.arth.2017.12.001. Epub 2017 Dec 13.

PMID:
29306574
14.

Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

Benoist GE, van Oort IM, Smeenk S, Javad A, Somford DM, Burger DM, Mehra N, van Erp NP.

Br J Clin Pharmacol. 2018 Jan;84(1):122-129. doi: 10.1111/bcp.13425. Epub 2017 Oct 18.

15.

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide.

Benoist GE, Hendriks RJ, Mulders PF, Gerritsen WR, Somford DM, Schalken JA, van Oort IM, Burger DM, van Erp NP.

Clin Pharmacokinet. 2016 Nov;55(11):1369-1380. Review.

16.

Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?

Wegelin O, van Melick HHE, Hooft L, Bosch JLHR, Reitsma HB, Barentsz JO, Somford DM.

Eur Urol. 2017 Apr;71(4):517-531. doi: 10.1016/j.eururo.2016.07.041. Epub 2016 Aug 25. Review.

PMID:
27568655
17.

An Ex Vivo Phantom Validation Study of an MRI-Transrectal Ultrasound Fusion Device for Targeted Prostate Biopsy.

Wegelin O, Henken KR, Somford DM, Breuking FA, Bosch RJ, van Swol CF, van Melick HH.

J Endourol. 2016 Jun;30(6):685-91. doi: 10.1089/end.2015.0864. Epub 2016 Mar 16.

PMID:
26886510
18.

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.

Arends TJ, Falke J, Lammers RJ, Somford DM, Hendriks JC, de Weijert MC, Arentsen HC, van der Heijden AG, Oosterwijk E, Alfred Witjes J.

World J Urol. 2015 Oct;33(10):1411-7. doi: 10.1007/s00345-014-1458-3. Epub 2014 Dec 10.

PMID:
25491674
19.

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.

Hoeks CM, Somford DM, van Oort IM, Vergunst H, Oddens JR, Smits GA, Roobol MJ, Bul M, Hambrock T, Witjes JA, Fütterer JJ, Hulsbergen-van de Kaa CA, Barentsz JO.

Invest Radiol. 2014 Mar;49(3):165-72. doi: 10.1097/RLI.0000000000000008.

PMID:
24220253
20.

Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Somford DM, Vreuls W, Jansen TS, van Basten JP, Vergunst H.

World J Urol. 2014 Apr;32(2):461-7. doi: 10.1007/s00345-013-1130-3. Epub 2013 Jul 20.

PMID:
23873356
21.

Editorial comment.

Somford DM.

J Urol. 2013 Sep;190(3):873. doi: 10.1016/j.juro.2013.03.129. Epub 2013 Jun 10. No abstract available.

PMID:
23763863
22.

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.

J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.

PMID:
23680307
23.

Re: Markus Graefen, Thorsten Schlomm. Active surveillance for low-risk prostate cancer: some questions are answered, but many questions remain. Eur Urol 2013;63:604-5.

Somford DM.

Eur Urol. 2013 Sep;64(3):e65-6. doi: 10.1016/j.eururo.2013.03.060. Epub 2013 Apr 11. No abstract available.

PMID:
23590811
24.

Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.

Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA, Hambrock T, Fütterer JJ, Witjes JA, Bangma CH, Vergunst H, Smits GA, Oddens JR, van Oort IM, Barentsz JO; MR-PRIAS Collaboration Group.

Invest Radiol. 2013 Mar;48(3):152-7. doi: 10.1097/RLI.0b013e31827b711e.

PMID:
23328910
25.

Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.

Somford DM, Hambrock T, Hulsbergen-van de Kaa CA, Fütterer JJ, van Oort IM, van Basten JP, Karthaus HF, Witjes JA, Barentsz JO.

Invest Radiol. 2012 Mar;47(3):153-8. doi: 10.1097/RLI.0b013e31823ea1f0.

PMID:
22293513
26.

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, Witjes JA, Heerschap A, Fütterer JJ.

Radiology. 2011 Oct;261(1):46-66. doi: 10.1148/radiol.11091822. Review.

PMID:
21931141
27.

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO.

Radiology. 2011 May;259(2):453-61. doi: 10.1148/radiol.11091409.

PMID:
21502392
28.

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy.

Somford DM, van Oort IM, Cosyns JP, Witjes JA, Kiemeney LA, Tombal B.

World J Urol. 2012 Feb;30(1):105-10. doi: 10.1007/s00345-010-0641-4. Epub 2011 Jan 15.

29.

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.

Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO.

J Urol. 2010 Feb;183(2):520-7. doi: 10.1016/j.juro.2009.10.022. Epub 2009 Dec 14.

PMID:
20006859
30.

[Multiparametric MRI for prostate cancer screening].

Hoeks CM, Fütterer JJ, Somford DM, van Oort IM, Huisman H, Barentsz JO.

Ned Tijdschr Geneeskd. 2009;153:B487. Review. Dutch.

PMID:
20003566
31.

Retraction of an intrathecal baclofen infusion catheter following suprapubic cystotomy: a case report.

Martens FM, Somford DM, van Kuppevelt DH, van den Burg MJ, Heesakkers JP.

J Rehabil Med. 2009 Jan;41(1):90-1. doi: 10.2340/16501977-0293.

32.

Diffusion and perfusion MR imaging of the prostate.

Somford DM, Fütterer JJ, Hambrock T, Barentsz JO.

Magn Reson Imaging Clin N Am. 2008 Nov;16(4):685-95, ix. doi: 10.1016/j.mric.2008.07.002. Review.

PMID:
18926431
33.

Association of early CT abnormalities, infarct size, and apparent diffusion coefficient reduction in acute ischemic stroke.

Somford DM, Marks MP, Thijs VN, Tong DC.

AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):933-8.

34.

Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging.

Thijs VN, Somford DM, Bammer R, Robberecht W, Moseley ME, Albers GW.

Stroke. 2004 Jan;35(1):94-8. Epub 2003 Dec 11.

PMID:
14671249
35.

Proximal and distal hyperattenuating middle cerebral artery signs at CT: different prognostic implications.

Somford DM, Nederkoorn PJ, Rutgers DR, Kappelle LJ, Mali WP, van der Grond J.

Radiology. 2002 Jun;223(3):667-71.

PMID:
12034933
36.

Radiologic-pathologic correlation of the hyperdense middle cerebral artery sign. A case report.

Rutgers DR, van der Grond J, Jansen GH, Somford DM, Mali WP.

Acta Radiol. 2001 Sep;42(5):467-9.

PMID:
11552883

Supplemental Content

Loading ...
Support Center